NASDAQ:PRLD

Prelude Therapeutics Stock Predictions

etoro logo Buy PRLD
*Your capital is at risk
$3.66
+0.160 (+4.57%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

PRLD Prediction Chart

PRLD Predictions History

Latest community submissions for PRLD.
Predictor Target Session Target Price Result Direction Accuracy Score
Apr 22, 2026 $4.80 +4.00% $4.31 X 88.52% 0
Apr 22, 2026 $4.84 +4.70% $4.31 X 87.77% 0
Apr 22, 2026 $4.48 -2.94% $4.31 V 95.96% 1
Apr 22, 2026 Bullish $4.31 X 0
Jan 22, 2025 $1.17 -4.46% $1.17 V 99.62% 5
Jan 22, 2025 $1.19 -2.79% $1.17 V 98.63% 2
Jan 22, 2025 Bullish $1.17 X 0
JS JS Pro
Feb 25, 2021 $66.14 +2.81% $64.33 X 97.19% 1
Kevin Ripper Kevin Ripper @KevinRipper.214730
Feb 25, 2021 $67.00 +4.15% $64.33 X 95.85% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PRLD with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT PRELUDE THERAPEUTICS INCORPORATED
Prelude Therapeutics
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid tumors, including glioblastoma multiforme. The company is also developing PRT1419, a potent and selecti...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE